Acute Shock Liver in Inferior ST-Segment Elevation Myocardial infarct with Total Atrioventricular block: A Case Report

Authors

  • Mochamad Rizky Hendiperdana Department of Cardiology Regional Public Hospital Pandan Arang of Boyolali, Indonesia
  • Sumardjo Sumardjo Gastroenterohepatology division, Department of Internal Medicine Regional Public Hospital Pandan Arang of Boyolali, Indonesia

Keywords:

shock liver, hypoxic hepatitis, cardiogenic shock, myocardial infarction

Abstract

Liver dysfunction frequently accompanies heart diseases, especially in hemodynamically unstable acute heart failure or cardiogenic shock. This condition is marked by significant elevation of liver transaminases and brings high morbidity and mortality for > 50 % of cases. Despite the high mortality rate, early recognition with prompt management results in the recovery of liver function. A 53-year-old man presented with late-onset non-reperfused inferior STEMI. The patient presented with persistent chest pain and shortness of breath. The electrocardiogram showed atrioventricular (AV) block grade III and ST-segment elevation evolution in the inferior lead. The patient was diagnosed with a late-onset inferior STEMI with cardiogenic shock and total AV block complication, acute shock liver, lactic acidosis, and acute renal failure. We administered inotropic and chronotropic support drugs as well as post-MI anti-remodelling therapy to treat heart failure (HF) and left ventricular (LV) systolic dysfunction, such as angiotensin-converting enzyme inhibitor and aldosterone antagonist, after systemic perfusion improved. Anti-ischemic therapy, such as antithrombotics, was also administered. Renal and liver function test evaluation after a week of patient discharge showed normalization of these parameters. There is no definite treatment strategy for shock liver. The management strategy is directed at the treatment of underlying causes. Hemodynamic insult is the mainstay therapeutic target. Recovery of liver transaminases was demonstrated after the underlying insult had been eliminated.

Author Biography

Mochamad Rizky Hendiperdana, Department of Cardiology Regional Public Hospital Pandan Arang of Boyolali, Indonesia

Cardiologist

References

Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease. JACC Hear Fail. 2019;7(2). doi:10.1016/j.jchf.2018.10.007

Chávez-Tapia NC, Balderas-Garces B V., Meza-Meneses P, et al. Hypoxic hepatitis in cardiac intensive care unit: A study of cardiovascular risk factors, clinical course, and outcomes. Ther Clin Risk Manag. 2014;10(1). doi:10.2147/TCRM.S59312

Waseem N, Chen PH. Hypoxic hepatitis: A review and clinical update. J Clin Transl Hepatol. 2016;4(3). doi:10.14218/JCTH.2016.00022

Soultati A, Dourakis SP. Liver dysfunction in the Intensive Care Unit. Ann Gastroenterol. 2005;18(1).

Tapper EB, Sengupta N, Bonder A. The incidence and outcomes of ischemic hepatitis: A systematic review with meta-analysis. Am J Med. 2015;128(12). doi:10.1016/j.amjmed.2015.07.033

Soleimanpour H, Safari S, Rahmani F, Nejabatian A, Alavian SM. Hepatic shock differential diagnosis and risk factors: A review article. Hepat Mon. 2015;15(10). doi:10.5812/hepatmon.27063

Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic Hepatitis: Clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore). 2003;82(6). doi:10.1097/01.md.0000101573.54295.bd

Fuhrmann V, Kneidinger N, Herkner H, et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011;37(8). doi:10.1007/s00134-011-2248-7

Tehrani BN, Truesdell AG, Psotka MA, et al. A standardized and comprehensive approach to the management of cardiogenic shock. JACC Hear Fail. 2020;8(11). doi:10.1016/j.jchf.2020.09.005

Gopar-Nieto R, González-Pacheco H, Arias-Mendoza A, et al. Non-reperfused ST-elevation myocardial infarction: notions from a low-to-middle-income country. Arch Cardiol Mex. 2023;93(1). doi:10.24875/ACM.21000312

Singh SM, FitzGerald G, Yan AT, et al. High-grade atrioventricular block in acute coronary syndromes: Insights from the global registry of acute coronary events. Eur Heart J. 2015;36(16). doi:10.1093/eurheartj/ehu357

Aguiar Rosa S, Timóteo AT, Ferreira L, et al. Complete atrioventricular block in acute coronary syndrome: prevalence, characterisation and implication on outcome. Eur Hear J Acute Cardiovasc Care. 2018;7(3). doi:10.1177/2048872617716387

Aplin M, Engstrøm T, Vejlstrup NG, Clemmensen P, Torp-Pedersen C, Køber L. Prognostic importance of complete atrioventricular block complicating acute myocardial infarction. Am J Cardiol. 2003;92(7). doi:10.1016/S0002-9149(03)00900-7

Hendiperdana MR. An Acute Anterior Reinfarction Complicating with Transient Symptomatic Total Atrioventricular Block. Indones J Cardiol. 2022;43(3). doi:10.30701/ijc.1216

Downloads

Published

2025-07-08

How to Cite

Hendiperdana, M. R., & Sumardjo, S. (2025). Acute Shock Liver in Inferior ST-Segment Elevation Myocardial infarct with Total Atrioventricular block: A Case Report. Acta Medica Indonesiana, 57(2), 257. Retrieved from http://www.actamedindones.org/index.php/ijim/article/view/2742